$HCWB Cashflow Statement | Understand Stock

$HCWB

$1.10 -$0.07 (5.98%) Close

$HCWB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Depreciation and accretion
Stock-based compensation
Unrealized (gain) on investments, net
Accretion of issuance costs
Commitment fee
Change in fair value of investment
Change in fair value of contingent liability
Gain on extinguishment of liability
Loss on sale of put shares
Loss on conversion of debt with related parties
Impairment of Long-Lived Asset
Realized (gain) on investments, net
Reduction in the carrying amount of right-of-use asset
Changes in the carrying amount of right-of-use asset
Reserve for credit losses
Changes in operating assets and liabilities:
Accounts receivable
Deposit for interest reserve
Prepaid expenses and other assets
Accounts payable and other liabilities
Operating lease liability
Net cash used in operating activities

Cash flows from investing activities:
Purchases of property and equipment
Proceeds for sale or maturities of short-term investments
Purchases of short-term investments
Purchases of long-term investments
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from PPP loan
Proceeds from the sale of Series C Preferred Stock
Issuance costs of initial public offering
Proceeds from issuance of Common Stock, net
Proceeds from issuance of Common Stock under SEPA, net
Proceeds from issuance of pre-funded warrants, net
Proceeds from common stock warrants
Proceeds from issuance of debt
Issuance costs for Common Stock, pre-funded warrants, and Common Stock warrants
Debt repayment
Net cash provided by financing activities

Net changes in cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the period
Cash and cash equivalents at the end of the period
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amounts capitalized
Noncash investing activities:
In-kind payment for license fee
Cumulative dividends earned, accrued and forfeited in the reporting period
Forfeiture of cumulative dividends, upon conversion of all Preferred Stock
PPP loan forgiveness
Operating lease liabilities arising from obtaining right-of-use assets
Operating lease liabilities arising from obtaining right-of -use assets
Capital expenditures accrued, but not yet paid
Purchases of property and equipment included in accounts payable
Purchases of property and equipment included in accounts payable and other liabilities
Reserve for credit losses

Noncash financing activities:
Extinguishment of restructured debt with related parties
Issuance of Common Stock, warrants and other rights upon extinguishment of restructured debt with related parties
Gain on extinguishment of debt with related parties
Equity dividend to investor

Comments